Objective To investigate the therapeutic effect and safety of PBSCT combined with high dose chemotherapy in the treatment of small cell lung cancer (SCLC).
目的研究外周血干细胞移植加高剂量化疗治疗小细胞肺癌的临床疗效和安全性。
Combined chemotherapy with multiple drugs at the standardized high dose is the key to a long survival time of patients with osteosarcoma of limbs.
结论肿瘤坏死率是评估生存率的重要指标，规范的大剂量多药联合化疗是骨肉瘤长期生存的重要保证。
Conclusion High-dose methotrexate combined with AT-1258 chemotherapy appeared to be an effective and safe regimen for patients with refractory or relapsed lymphoma.
结论大剂量甲氨喋呤联合消瘤芥治疗复发难治性恶性淋巴瘤是一种安全有效的方案。
Conclusion High-dose methotrexate combined with AT-1258 chemotherapy appeared to be an effective and safe regimen for patients with refractory or relapsed lymphoma.
结论大剂量甲氨喋呤联合消瘤芥治疗复发难治性恶性淋巴瘤是一种安全有效的方案。
应用推荐